logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Acute isoniazid exposures and antidote availability.

    Article - En anglais

    Background 

    Over the past 10 years the reported incidence of acute isoniazid (INH) - related poisonings has increased, with 507 cases reported in 1996.

    Parenteral pyridoxine is the antidote for INH-induced seizures, but 5-g aliquot recommended to treat an ingestion of unknown quantity of INH is not always readily available to emergency physicians.

    Objective 

    To determine the hospital availability of pyridoxine.

    Methods 

    One hundred thirty questionnaires were distributed nationwide to the pharmacies and emergency departments (ED) of hospitals containing pediatric emergency medicine (PEM) fellowships and/or emergency medicine (EM) residencies Questions were posed regarding the availability, quantity, location, and deemed importance of pyridoxine at each institution.

    Results 

    Responses were received from 81% of the hospitals with fellowships and 80% of the hospitals with residencies.

    Half of the former and one third of the latter reported not having the recommended 5-g aliquot available.

    Eighty percent of the hospitals with PEM programs and 71% with EM residencies with an adequate stock store it in the hospital's pharmacy, as opposed to in the ED.

    Thirty-four states were represented, 18 of which have experienced an increase in tuberculosis (TB) from 1993 to 1994 ; 6/18 (33%) of those did not have the pyridoxine available, and 7/18 (39%) did not deem it necessary. (...)

    Mots-clés Pascal : Isoniazide, Antituberculeux, Chimiothérapie, Pyridoxine, Intoxication, Antidote, Tuberculose, Mycobactériose, Bactériose, Infection, Mycobacterium tuberculosis, Mycobacteriaceae, Mycobacteriales, Actinomycetes, Bactérie, Traitement, Aigu, Disponibilité, Hôpital, Système nerveux pathologie, Enfant, Homme

    Mots-clés Pascal anglais : Isoniazid, Antituberculous agent, Chemotherapy, Pyridoxine, Poisoning, Antidote, Tuberculosis, Mycobacterial infection, Bacteriosis, Infection, Mycobacterium tuberculosis, Mycobacteriaceae, Mycobacteriales, Actinomycetes, Bacteria, Treatment, Acute, Availability, Hospital, Nervous system diseases, Child, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0241595

    Code Inist : 002B02V. Création : 16/11/1999.